European Biotech Acquisition Corp. Warrant
EBACW
EBACW was delisted on the 2nd of March, 2023.
29 hedge funds and large institutions have $858K invested in European Biotech Acquisition Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 32 → 29 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
69% less capital invested
Capital invested by funds: $2.73M → $858K (-$1.88M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$23.7K |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
+$3.64K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$546 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.84M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$9K |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$5.46K |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
-$5K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WP
26
Woodline Partners
San Francisco,
California
| – | -$5K | -91,666 | Closed |
|
|
PMAM
27
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| – | -$9K | -91,665 | Closed |
|
|
FTCM
28
Fir Tree Capital Management
New York
| – | -$5K | -49,631 | Closed |
|
|
MF
29
Magnetar Financial
Evanston,
Illinois
| – | -$3 | -29,532 | Closed |
|
|
OMC
30
Old Mission Capital
Chicago,
Illinois
| – | -$1K | -14,388 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$11 | -100 | -10% |
|
|
ETH
32
Exos TFP Holdings
New York
| – | +$93 | +850 | New |
|
EBACW Hedge Fund Activity: Q3 2022 in Review
29 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q3 2022, worth a combined $858K — down 69% from $2.73M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of EBACW and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, opening a new position worth an estimated $23.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.84M sold.
- 29 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q3 2022, down from 32 in Q2 2022.
- Funds reported $858K of European Biotech Acquisition Corp. Warrant stock for Q3 2022, down 69% quarter-over-quarter.
- 3 funds opened new European Biotech Acquisition Corp. Warrant positions in Q3 2022 and 6 closed out, a net change of -3 holders.
- The largest European Biotech Acquisition Corp. Warrant buyer in Q3 2022 was Clear Street, an estimated $23.7K added.
- The largest European Biotech Acquisition Corp. Warrant seller in Q3 2022 was Mangrove Partners, an estimated $1.84M sold.
Based on aggregated 13F filings for Q3 2022.